Mark Huffman has been a consumer news reporter for ConsumerAffairs since 2004. He covers real estate, gas prices and the economy and has reported extensively on negative-option sales. He was ...

UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

Boehringer Ingelheim has said it will take its obesity drug candidate survodutide into a phase 3 programme later this year. The glucagon/GLP-1 receptor dual agonist – partnered with Zealand ...

A novel antibiotic recently approved for treatment of urinary tract infections also shows efficacy against gonorrhea, according to the results of a phase 3 randomized trial published yesterday in The ...

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.